Cookie Declaration

MM0011 Rev C

ExThera Medical Corporation
757 Arnold Drive, Suite B
Martinez, California 94553

Privacy Policy | Terms of Use | Contact Us
p: (925) 839-2060 | f: (925) 839-2075
[email protected]

The Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) attained CE Mark in 2019 and is commercially available in the EU for the treatment of blood stream infections. The Seraph 100 device has neither been cleared nor approved by the U.S. Food and Drug Administration (FDA) for any indication. The Seraph 100 has been authorized by FDA under an Emergency Use Authorization (EUA) to treat patients with COVID-19 infection. The Seraph 100 is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of the Seraph 100 device under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

The ONCObind™ Procedure Hemoperfusion Filter is approved for Investigational Device Exemption (IDE) study and is not commercially available.

EXTHERA MEDICAL, the ExThera Medical Logo, SERAPH, the Seraph Logo, MICROBIND, and ONCOBIND are trademarks or registered trademarks of ExThera Medical Corporation in the U.S. and/or other countries.
2024 Exthera Medical. All rights reserved. MM0011 Rev D

Website Disclaimer: External Content

ExThera Medical includes links to various publications and medical journals to help users find additional helpful information. These links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or approval by ExThera Medical of any of the products, services, or opinions of the linked websites. ExThera Medical bears no responsibility for the external site’s accuracy, legality, content, or subsequent links. Contact the external site for answers to questions regarding its content.

When you click on the various publications and medical journals, you will leave ExThera Medical’s website.

In case of questions, please get in touch with us here.

MM0004 Rev E

Go to Publications!